Immunogenicity 13230
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
GPD1L
Transcript ID
uc003cew.3
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (351 aa)
MAAAP
1
LKVCI
6
VGSGN
11
WGSAV
16
AKIIG
21
NNVKK
26
LQKFA
31
STVKM
36
WVFEE
41
TVNGR
46
KLTDI
51
INNDH
56
ENVKY
61
LPGHK
66
LPENV
71
VAMSN
76
LSEAV
81
QDADL
86
LVFVI
91
PHQFI
96
HRICD
101
EITGR
106
VPKKA
111
LGITL
116
IKGID
121
EGPEG
126
LKLIS
131
DIIRE
136
KMGID
141
ISVLM
146
GANIA
151
NEVAA
156
EKFCE
161
TTIGS
166
KVMEN
171
GLLFK
176
ELLQT
181
PNFRI
186
TVVDD
191
ADTVE
196
LCGAL
201
KNIVA
206
VGAGF
211
CDGLR
216
CGDNT
221
KAAVI
226
RLGLM
231
EMIAF
236
ARIFC
241
KGQVS
246
TATFL
251
ESCGV
256
ADLIT
261
TCYGG
266
RNRRV
271
AEAFA
276
RTGKT
281
IEELE
286
KEMLN
291
GQKLQ
296
GPQTS
301
AEVYR
306
ILKQK
311
GLLDK
316
FPLFT
321
AVYQI
326
CYESR
331
PVQEM
336
LSCLQ
341
SHPEH
346
T
351
Mutation Information
DNA mutation:
None
Peptide Range:
114 ~ 138
Mut AA position:
126 (13 in Wild Type peptide)
Alignment
Wild Type:
"KALGITLIKGIDEGPEGLKLISDII
||||||||||||.||||||||||||
Mutant:
KALGITLIKGIDKGPEGLKLISDII"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) GPD1L
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay